Form D · Biotechnology

InnAVasc Medical, Inc.

Durham, NC · CIK 0001671622

Offering snapshot reported Nov 10, 2021 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
41
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 4, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 10, 2021Initial$1,000,000No comparison41SEC filing
Apr 21, 2020Initial$414,501No comparison20SEC filing
Oct 15, 2018Initial$500,000No comparison17SEC filing
Nov 4, 2016Initial$2,148,672No comparison39SEC filing
Apr 14, 2016Initial$520,000No comparison14SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-420663

Source: Form D, filed Nov 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dani Bolognesi Director
Greg Davis Director
C. Steven Duncker Director
Stephen Duncker Director
C Steven Duncker Director
Shawn Gage Executive
Kenneth Gall Director
Joseph Knight Director, Executive
Jeffrey Lawson Director
Roberto Duane Manson Executive
Craig Nichols Executive
William N, Starling Director
William Starling,Jr. Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
110 Swift Avenue
Durham, NC, 27705